文档介绍：Alteplase for treating acute
ischaemic stroke (review of
technology appraisal
guidance 122)

Issued: September 2012
NICE technology appraisal guidance 264
guidance..uk/ta264
NHS Evidence has accredited the process used by the Centre for Health Technology Evaluation at NICE
to produce technology appraisals guidance. Accreditation is valid for 5 years from September 2009 and
applies to guidance produced since June 2008 using the processes described in NICE's 'The guide to the
methods of technology appraisal' (2008). More information on accreditation can be viewed at

© NICE 2012
Alteplase for treating acute ischaemic stroke (review of NICE technology appraisal guidance 264
technology appraisal guidance 122)
Contents

1 Guidance .............................................................................................................................. 3
2 The technology ..................................................................................................................... 4
3 The manufacturer's submission ............................................................................................ 5
4 Consideration of the evidence ............................................................................................ 15
Summary of mittee's key conclusions ......................................................... 20
5 Implementation ................................................................................................................... 28
6 mendations for further research .............................................................................. 29
7 Related NICE guidance ...................................................................................................... 30
8 Review of guidance ............................................................................................................ 31
Appendix A: mittee members and NICE project team ...................